NIPT Prime & NIPT Ultra
Non-Invasive Prenatal Testing that analyzes cell-free fetal DNA in maternal blood — offering clarity, confidence, and peace of mind from as early as 10 weeks.
NIPT is a highly accurate, non-invasive screening test that analyzes cell-free fetal DNA (cfDNA) circulating in maternal blood to assess the risk of chromosomal abnormalities.
No needles. No risk to the pregnancy. Just a simple maternal blood draw that offers profound genomic insight – available at Meril Genomics in two advanced configurations.
A simple 10 mL maternal blood draw — no amniocentesis or CVS required for screening.
Next Generation Sequencing with advanced bioinformatics for maximum precision and reliability.
Results interpreted per international clinical guidelines with dedicated genetic counseling support.
Choose the screening depth that fits your clinical needs — from focused chromosomal analysis to expanded microdeletion coverage.
Comprehensive screening for the most clinically significant chromosomal conditions — ideal for routine prenatal care. Comprehensive screening for the most clinically significant chromosomal conditions — ideal for routine prenatal care.
Maternal peripheral blood collection (10 mL)
High-depth Next Generation Sequencing
Advanced statistical and bioinformatics algorithms
Strict quality control and contamination monitoring
Validated reporting framework
All results are interpreted following international clinical guidelines, and genetic counseling support is available when needed.